Home›Companies›Healthcare›Ascella Biosystems

Ascella Biosystems, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 28, 2023·Suggest an edit

About Ascella Biosystems

Ascella Biosystems is a private company based in San Francisco, California, incorporated in 2020 in Delaware. It has reported $6,331,965 raised in one offering on Form D since December 2023. Its chief executive is Deepak Boggavarapu.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 18, 2023Dec 28, 2023$6,331,965fully sold11$575KEquity, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ascella Biosystems's Form D filed Dec 28, 2023.

JK
Junichi Kajimoto
Executive officer and director
SI
Satoru Iino
Director
DB
Deepak Boggavarapu
Chief Executive Officer and director

Sources

  1. SECASCELLA BIOSYSTEMS, INC. filing history